ストックスクリーナーアプリを入手
2.82
9.30%
0.24
プレマーケット:
2.92
0.10
+3.55%
Bioxcel Therapeutics Inc (BTAI) 最新ニュース
BioXcel Therapeutics stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada
Real time scanner hits for BioXcel Therapeutics Inc. explained2025 Volatility Report & Weekly High Return Opportunities - newser.com
Fundamentals Check: Is BioXcel Therapeutics Inc benefiting from interest rate changesWeekly Trade Report & Technical Analysis for Trade Confirmation - خودرو بانک
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Short Interest Up 166.4% in August - MarketBeat
ETF Watch: How cyclical is BioXcel Therapeutics Incs revenue streamAnalyst Upgrade & Risk Controlled Stock Pick Alerts - خودرو بانک
Aug Reactions: How cyclical is BioXcel Therapeutics Incs revenue streamJuly 2025 Trends & Reliable Price Breakout Alerts - khodrobank.com
BioXcel Therapeutics regains Nasdaq compliance after MVLS issue By Investing.com - Investing.com South Africa
BioXcel Therapeutics regains compliance with Nasdaq market value of listed securities requirements - MarketScreener
BioXcel Therapeutics Regains Compliance With Nasdaq Market Value of Listed Securities Requirements - 富途牛牛
Volume spikes in BioXcel Therapeutics Inc. stock – what they meanMarket Weekly Review & AI Driven Price Predictions - newser.com
BioXcel Therapeutics (BTAI) Regains Nasdaq Compliance - GuruFocus
BioXcel Therapeutics regains Nasdaq compliance after MVLS issue - Investing.com
BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements - The Manila Times
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Risk Check: How does BioXcel Therapeutics Inc correlate with Nasdaq2025 Price Action Summary & Free High Return Stock Watch Alerts - خودرو بانک
Institutional scanner results for BioXcel Therapeutics Inc.July 2025 Intraday Action & Daily Oversold Bounce Ideas - newser.com
Dip Buying: Is BioXcel Therapeutics Inc stock good for income investorsQuarterly Earnings Report & Verified Swing Trading Watchlists - خودرو بانک
Does BioXcel Therapeutics Inc have a competitive edgeMarket Trend Summary & AI Driven Price Forecasts - khodrobank.com
Profit Recap: Can BioXcel Therapeutics Inc. lead its sector in growthEarnings Risk Summary & Weekly Breakout Watchlists - خودرو بانک
How does Deswell Industries Inc compare to its peersMarket Performance Report & Low Drawdown Investment Ideas - خودرو بانک
Quarterly Trades: Is AutoNation Inc. affected by consumer sentimentJuly 2025 Levels & Consistent Growth Stock Picks - خودرو بانک
BTAI Secures $37.3M Through Equity Distribution and Warrant Exercises - GuruFocus
BTAI Completes Enrollment in Key Clinical Study - GuruFocus
BioXcel Therapeutics, Inc. Provides Clinical Trial Update - MarketScreener
Guidance Update: Does BioXcel Therapeutics Inc stock have upside surprise potentialWatch List & Technical Buy Zone Confirmations - خودرو بانک
Using economic indicators to assess BioXcel Therapeutics Inc. potentialGDP Growth & Reliable Intraday Trade Plans - newser.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bioxcel Therapeutics (BTAI) and Alignment Healthcare (ALHC) - The Globe and Mail
Murchinson Ltd. Purchases Shares of 136,076 BioXcel Therapeutics, Inc. $BTAI - MarketBeat
BioXcel Therapeutics stock price target raised to $4 by Mizuho on positive trial data - Investing.com
BioXcel Therapeutics Reports Positive Phase 3 Trial Results - MSN
BioXcel reports positive efficacy data for at-home agitation treatment - Investing.com India
Transcript : BioXcel Therapeutics, Inc.Special Call - MarketScreener
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar PatientsBioXcel Therapeutics (NASDAQ:BTAI) - Benzinga
Bioxcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study - Menafn.com
BioXcel Therapeutics : SERENITY AT Home Topline September 10 - MarketScreener
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study - Stocktwits
BioXcel reports positive efficacy data for at-home agitation treatment By Investing.com - Investing.com Canada
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data From SERENITY At-Home Study - Nasdaq
BioXcel Therapeutics Announces Positive Phase 3 Trial Results for BXCL501 in Outpatient Treatment of Agitation Associated with Bipolar Disorders and Schizophrenia - Quiver Quantitative
BioXcel Therapeutics Reports Positive Topline Exploratory - GlobeNewswire
BioXcel Therapeutics, Inc. Reports Positive Topline Exploratory Efficacy Data from Serveity At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia - MarketScreener
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data From SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated With Bipolar Disorders or Schizophrenia - 富途牛牛
BioXcel Therapeutics at H.C. Wainwright: Expanding IGALMI’s Reach By Investing.com - Investing.com Canada
BioXcel Therapeutics at H.C. Wainwright: Expanding IGALMI’s Reach - Investing.com
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Short Interest Update - MarketBeat
BioXcel Therapeutics Receives Positive FDA Feedback - MSN
Can momentum traders help lift BioXcel Therapeutics Inc.Weekly Market Summary & Fast Entry and Exit Trade Plans - Newser
Technical signs of recovery in BioXcel Therapeutics Inc.Insider Selling & Daily Chart Pattern Signal Reports - Newser
Canaccord Genuity Reaffirms Their Buy Rating on Bioxcel Therapeutics (BTAI) - The Globe and Mail
Is BioXcel Therapeutics Inc. part of any major indexJuly 2025 Macro Moves & Verified Swing Trading Watchlist - خودرو بانک
Published on: 2025-09-05 14:41:42 - Newser
Using data models to predict BioXcel Therapeutics Inc. stock movementSwing Trade & Weekly Watchlist for Hot Stocks - Newser
Can machine learning forecast BioXcel Therapeutics Inc. recoveryTrade Risk Report & Fast Entry High Yield Stock Tips - Newser
Can a trend reversal in BioXcel Therapeutics Inc. lead to recovery2025 Earnings Impact & Precise Swing Trade Alerts - Newser
What candlestick patterns are forming on BioXcel Therapeutics Inc.Earnings Overview Report & Fast Momentum Stock Entry Tips - Newser
2.43%
大文字化:
|
ボリューム (24 時間):